Literature DB >> 22166353

On the mechanism and rate of gold incorporation into thiol-dependent flavoreductases.

Fulvio Saccoccia1, Francesco Angelucci, Giovanna Boumis, Maurizio Brunori, Adriana E Miele, David L Williams, Andrea Bellelli.   

Abstract

NADPH-dependent flavoreductases are important drug targets. During their enzymatic cycle thiolates and selenolates that have high affinity for transition metals are generated. Auranofin (AF), a gold-containing compound, is classified by the World Health Organization as an antirheumatic agent and it is indicated as the scaffold for the development of new anticancer and antiparasitic drugs. AF inhibits selenocysteine-containing flavoreductases (thioredoxin reductase and thioredoxin glutathione reductase) more effectively than non Se-containing ones (glutathione reductase); this preference has been ascribed to the high affinity of selenium for gold. We solved the 3D structure of the Se-containing Thioredoxin Glutathione Reductase from the human parasite Schistosoma mansoni complexed with Au and our results challenge this view: we believe that the relative velocity of the reaction rather than the relative affinity, depends on the presence of Sec residues, which appear to dictate AF selectivity. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22166353      PMCID: PMC3396563          DOI: 10.1016/j.jinorgbio.2011.11.005

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  33 in total

Review 1.  Differing views of the role of selenium in thioredoxin reductase.

Authors:  Robert J Hondal; Erik L Ruggles
Journal:  Amino Acids       Date:  2010-02-21       Impact factor: 3.520

2.  Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography.

Authors:  Francesco Angelucci; Daniela Dimastrogiovanni; Giovanna Boumis; Maurizio Brunori; Adriana E Miele; Fulvio Saccoccia; Andrea Bellelli
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

3.  Structural and functional characterization of Schistosoma mansoni Thioredoxin.

Authors:  Giovanna Boumis; Francesco Angelucci; Andrea Bellelli; Maurizio Brunori; Daniela Dimastrogiovanni; Adriana E Miele
Journal:  Protein Sci       Date:  2011-05-05       Impact factor: 6.725

4.  Selenium and sulfur in exchange reactions: a comparative study.

Authors:  Daniel Steinmann; Thomas Nauser; Willem H Koppenol
Journal:  J Org Chem       Date:  2010-10-01       Impact factor: 4.354

5.  Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds.

Authors:  S Gromer; L D Arscott; C H Williams; R H Schirmer; K Becker
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

6.  Acid-base catalysis in the mechanism of thioredoxin reductase from Drosophila melanogaster.

Authors:  Hsin-Hung Huang; L David Arscott; David P Ballou; Charles H Williams
Journal:  Biochemistry       Date:  2008-01-23       Impact factor: 3.162

7.  Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).

Authors:  Yo Omata; Matt Folan; Melissa Shaw; Regina L Messer; Petra E Lockwood; David Hobbs; Serge Bouillaguet; Hidehiko Sano; Jill B Lewis; John C Wataha
Journal:  Toxicol In Vitro       Date:  2006-02-28       Impact factor: 3.500

8.  Molecular basis of antimony treatment in leishmaniasis.

Authors:  Paola Baiocco; Gianni Colotti; Stefano Franceschini; Andrea Ilari
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

9.  Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

Authors:  James L Hickey; Rasha A Ruhayel; Peter J Barnard; Murray V Baker; Susan J Berners-Price; Aleksandra Filipovska
Journal:  J Am Chem Soc       Date:  2008-08-26       Impact factor: 15.419

10.  Molecular basis of metal-ion selectivity and zeptomolar sensitivity by CueR.

Authors:  Anita Changela; Kui Chen; Yi Xue; Jackie Holschen; Caryn E Outten; Thomas V O'Halloran; Alfonso Mondragón
Journal:  Science       Date:  2003-09-05       Impact factor: 47.728

View more
  13 in total

1.  A Hybrid of Amodiaquine and Primaquine Linked by Gold(I) Is a Multistage Antimalarial Agent Targeting Heme Detoxification and Thiol Redox Homeostasis.

Authors:  Caroline De Souza Pereira; Helenita Costa Quadros; Samuel Yaw Aboagye; Diana Fontinha; Sarah D'Alessandro; Margaret Elizabeth Byrne; Mathieu Gendrot; Isabelle Fonta; Joel Mosnier; Diogo Rodrigo M Moreira; Nicoletta Basilico; David L Williams; Miguel Prudêncio; Bruno Pradines; Maribel Navarro
Journal:  Pharmaceutics       Date:  2022-06-12       Impact factor: 6.525

Review 2.  New drug target in protozoan parasites: the role of thioredoxin reductase.

Authors:  Rosa M Andrade; Sharon L Reed
Journal:  Front Microbiol       Date:  2015-09-30       Impact factor: 5.640

3.  Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models.

Authors:  Jan Hošek; Ján Vančo; Pavel Štarha; Lenka Paráková; Zdeněk Trávníček
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

4.  Gold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agents.

Authors:  Ján Vančo; Jana Gáliková; Jan Hošek; Zdeněk Dvořák; Lenka Paráková; Zdeněk Trávníček
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

5.  Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.

Authors:  Hui Wang; Soumaya Bouzakoura; Sven de Mey; Heng Jiang; Kalun Law; Inès Dufait; Cyril Corbet; Valeri Verovski; Thierry Gevaert; Olivier Feron; Dirk Van den Berge; Guy Storme; Mark De Ridder
Journal:  Oncotarget       Date:  2017-05-30

6.  Phosphinogold(I) dithiocarbamate complexes: effect of the nature of phosphine ligand on anticancer properties.

Authors:  Frankline K Keter; Ilia A Guzei; Margo Nell; Werner E van Zyl; James Darkwa
Journal:  Inorg Chem       Date:  2014-01-29       Impact factor: 5.165

7.  Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities.

Authors:  Radka Křikavová; Jan Hošek; Ján Vančo; Jakub Hutyra; Zdeněk Dvořák; Zdeněk Trávníček
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 8.  Thioredoxin reductase and its inhibitors.

Authors:  Fulvio Saccoccia; Francesco Angelucci; Giovanna Boumis; Daniela Carotti; Gianni Desiato; Adriana E Miele; Andrea Bellelli
Journal:  Curr Protein Pept Sci       Date:  2014       Impact factor: 3.272

9.  Auranofin is a potent suppressor of osteosarcoma metastasis.

Authors:  Eleni Topkas; Na Cai; Andrew Cumming; Mehlika Hazar-Rethinam; Orla Margaret Gannon; Melinda Burgess; Nicholas Andrew Saunders; Liliana Endo-Munoz
Journal:  Oncotarget       Date:  2016-01-05

10.  Planarians as models to investigate the bioactivity of gold(I) complexes in vivo.

Authors:  Luiza G Tunes; John M Allen; Ricardo M Zayas; Rubens L do Monte-Neto
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.